Simple Summary Chronic alcoholic pancreatitis displays a cumulative risk of pancreatic
cancer estimated at 4% after 15 to 20 years, this risk being higher for hereditary pancreatitis …

Technology (CGIT) conducted a 1-day workshop to discuss endoscopic ultrasound–guided
tissue acquisition (EUS-TA), focusing on the variables that impact outcomes associated with …

Background and Aims Several studies have compared EUS-guided FNA with fine-needle
biopsy (FNB), but none have proven superiority. We performed a multicenter randomized …

The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …

Pancreatic cancer (PC) is a highly malignant tumor occurring in the digestive system.
Currently, there is a lack of specific and effective interventions for PC; thus, further …

Genetic alterations in pancreatic tumors can usually be classified in:(1) Mutational activation
of oncogenes;(2) Inactivation of tumor suppressor genes; and (3) Inactivation of genome …

Pancreatic cancer (PC) is a highly lethal cancer. Despite a significant advancement in
cancer treatment, the mortality rate of PC is nearly identical to the incidence rates. Early …

Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease, therefore
stratification of patients is essential to predict their responses to therapies and to choose the …

Aims In cystic and solid pancreatic lesions, KRAS mutational status refines the diagnosis of
uncertain endoscopic ultrasound (EUS) aspirates. This test should have a fast turnaround …

Applications of precision oncology strategies rely on accurate tumor genotyping from
clinically available specimens. Fine needle aspirations (FNA) are frequently obtained in …